Ferry Ossendorp

18.0k total citations · 3 hit papers
228 papers, 13.7k citations indexed

About

Ferry Ossendorp is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ferry Ossendorp has authored 228 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Immunology, 91 papers in Molecular Biology and 58 papers in Oncology. Recurrent topics in Ferry Ossendorp's work include Immunotherapy and Immune Responses (156 papers), T-cell and B-cell Immunology (55 papers) and Immune Cell Function and Interaction (51 papers). Ferry Ossendorp is often cited by papers focused on Immunotherapy and Immune Responses (156 papers), T-cell and B-cell Immunology (55 papers) and Immune Cell Function and Interaction (51 papers). Ferry Ossendorp collaborates with scholars based in Netherlands, United States and Germany. Ferry Ossendorp's co-authors include Cornelis J.M. Melief, Sjoerd H. van der Burg, Thorbald van Hall, Ramon Arens, Marcel Camps, Luis J. Cruz, Marieke F. Fransen, René E. M. Toes, Wim Jiskoot and Rienk Offringa and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ferry Ossendorp

225 papers receiving 13.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic cancer vaccines

2015 972 citations Cornelis J.M. Melief, Thorbald van Hall et al. profile →
Vaccines for established cancer: overcoming the challenges posed by immune evasion

2016 557 citations Sjoerd H. van der Burg, Ramon Arens et al. profile →
Current Challenges and Opportunities of Photodynamic Therapy against Cancer

2023 102 citations Luis J. Cruz, Ferry Ossendorp et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ferry Ossendorp	9.3k	5.2k	3.8k	1.7k	1.1k	228	13.7k
I. Jolanda M. de Vries	11.0k 1.2×	4.6k 0.9×	6.5k 1.7×	1.4k 0.8×	857 0.8×	250	16.1k
Jianzhu Chen	7.9k 0.8×	5.4k 1.0×	2.5k 0.6×	1.1k 0.6×	1.5k 1.4×	211	14.9k
Özlem Türeci	7.4k 0.8×	8.7k 1.7×	4.4k 1.2×	732 0.4×	1.7k 1.5×	181	15.0k
Peter Van Endert	8.4k 0.9×	4.6k 0.9×	3.7k 1.0×	828 0.5×	1.7k 1.6×	171	13.6k
Karolina Palucka	14.6k 1.6×	4.8k 0.9×	4.8k 1.3×	739 0.4×	930 0.9×	126	19.0k
Tanja D. de Gruijl	7.2k 0.8×	3.9k 0.8×	5.2k 1.4×	844 0.5×	784 0.7×	326	12.6k
Glenn Dranoff	15.7k 1.7×	6.7k 1.3×	12.4k 3.2×	2.3k 1.3×	1.7k 1.6×	188	25.4k
Nina Bhardwaj	20.6k 2.2×	8.2k 1.6×	7.7k 2.0×	900 0.5×	1.4k 1.3×	332	27.6k
James J. Mulé	9.1k 1.0×	3.6k 0.7×	6.1k 1.6×	427 0.2×	1.5k 1.4×	167	12.8k
Gerd Ritter	9.2k 1.0×	5.6k 1.1×	5.4k 1.4×	445 0.3×	812 0.8×	182	14.2k

Countries citing papers authored by Ferry Ossendorp

Since Specialization

Citations

This map shows the geographic impact of Ferry Ossendorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferry Ossendorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferry Ossendorp more than expected).

Fields of papers citing papers by Ferry Ossendorp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferry Ossendorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferry Ossendorp. The network helps show where Ferry Ossendorp may publish in the future.

Co-authorship network of co-authors of Ferry Ossendorp

This figure shows the co-authorship network connecting the top 25 collaborators of Ferry Ossendorp. A scholar is included among the top collaborators of Ferry Ossendorp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferry Ossendorp. Ferry Ossendorp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Middelburg, Jim, Marjolein Sluijter, Katy A. Lloyd, et al.. (2024). T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors. Nature Communications. 15(1). 48–48. 17 indexed citations

Camps, Marcel, George M. C. Janssen, Peter A. van Veelen, et al.. (2021). Bioorthogonal protein labelling enables the study of antigen processing of citrullinated and carbamylated auto-antigens. RSC Chemical Biology. 2(3). 855–862. 6 indexed citations

Fransen, Marieke F., Thorbald van Hall, & Ferry Ossendorp. (2021). Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights. International Journal of Molecular Sciences. 22(17). 9401–9401. 25 indexed citations

Brouwers, Conny, Margot M. Linssen, Marcel Camps, et al.. (2020). Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatment. Scientific Reports. 10(1). 3933–3933. 5 indexed citations

Ossendorp, Ferry, et al.. (2019). Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and Cytosplore. Journal of Visualized Experiments.

Camps, Marcel, Jitske van den Bulk, Elena Tondini, et al.. (2019). Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer. OncoImmunology. 9(1). 1673125–1673125. 56 indexed citations

Tondini, Elena, Tsolère Arakelian, Koen Oosterhuis, et al.. (2019). A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control. OncoImmunology. 8(11). 1652539–1652539. 52 indexed citations

Tondini, Elena, Chun Yin Jerry Lau, Tina Vermonden, et al.. (2019). Cationic synthetic long peptides-loaded nanogels: An efficient therapeutic vaccine formulation for induction of T-cell responses. Journal of Controlled Release. 315. 114–125. 39 indexed citations

Camps, Marcel, Tracy J. Ruckwardt, Elmer Maurits, et al.. (2018). Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified Epitopes. ACS Chemical Biology. 13(6). 1569–1576. 34 indexed citations

10.

Breukel, Cor, Jill Claassens, Conny Brouwers, et al.. (2018). High FcγR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody Therapy. The Journal of Immunology. 201(12). 3741–3749. 7 indexed citations

11.

Fransen, Marieke F., Mark J.A. Schoonderwoerd, Philipp Knopf, et al.. (2018). Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy. JCI Insight. 3(23). 265 indexed citations

12.

Doorduijn, Elien M., Marjolein Sluijter, Daniela Salvatori, et al.. (2017). CD4+ T Cell and NK Cell Interplay Key to Regression of MHC Class Ilow Tumors upon TLR7/8 Agonist Therapy. Cancer Immunology Research. 5(8). 642–653. 36 indexed citations

13.

Varypataki, Eleni Maria, Naomi Benne, Joke A. Bouwstra, Wim Jiskoot, & Ferry Ossendorp. (2017). Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines. Cancer Immunology Research. 5(3). 222–233. 57 indexed citations

14.

Kleinovink, Jan Willem, Thorbald van Hall, Ferry Ossendorp, & Marieke F. Fransen. (2017). PD-L1 immune suppression in cancer: Tumor cells or host cells?. OncoImmunology. e1325982–e1325982. 13 indexed citations

15.

Kleinovink, Jan Willem, Thomas J. Snoeks, Marieke F. Fransen, et al.. (2015). Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors. Clinical Cancer Research. 22(6). 1459–1468. 96 indexed citations

16.

Zom, Gijs G., Selina Khan, Cedrik M. Britten, et al.. (2014). Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand–Peptide Conjugates. Cancer Immunology Research. 2(8). 756–764. 81 indexed citations

17.

Sluis, Tetje C. van der, Suzanne van Duikeren, Ekaterina S. Jordanova, et al.. (2014). Vaccine-Induced Tumor Necrosis Factor–Producing T Cells Synergize with Cisplatin to Promote Tumor Cell Death. Clinical Cancer Research. 21(4). 781–794. 60 indexed citations

18.

Fransen, Marieke F., Tetje C. van der Sluis, Ferry Ossendorp, Ramon Arens, & Cornelis J.M. Melief. (2013). Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell–Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects. Clinical Cancer Research. 19(19). 5381–5389. 159 indexed citations

19.

Boer, Mark de, Ferry Ossendorp, Peter F. Bruning, & J. M. Tager. (1987). Direct Evidence for a Primary Immune Response of Murine B-Lymphocytes After In Vitro Immunization of Dissociated Splenocytes. Hybridoma. 6(3). 253–258. 10 indexed citations

20.

Boer, Mark de, Peter J.J. Admiraal, Kasper Kok, et al.. (1987). Characterization of Five Monoclonal Antibodies Obtained After Immunization In Vitro with a Synthetic 19-Amino Acid Peptide of Thyroglobulin. Hybridoma. 6(6). 655–662. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact